GLIOBLASTOMA MULTIFORME, ADULT
Clinical trials for GLIOBLASTOMA MULTIFORME, ADULT explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME, ADULT trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric fields plus targeted radiation may boost survival in recurrent glioblastoma
Disease control Recruiting nowThis study is for adults with recurrent glioblastoma, an aggressive brain cancer. It tests whether adding a precise type of radiation (stereotactic radiosurgery guided by a special PET scan) to a device that delivers electric fields to the brain (TTFields) helps people live longe…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: NA • Sponsor: Prof. Franciszek Lukaszczyk Memorial Oncology Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Brain cancer breakthrough? new trial delivers drug straight to tumor
Disease control Recruiting nowThis phase III trial is testing whether delivering the drug bevacizumab (Avastin) directly to the brain through a catheter, along with standard chemo and radiation, can help people with newly diagnosed glioblastoma live longer. The study will enroll 432 adults with this aggressiv…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Surgical flap may open door to better brain tumor treatment
Disease control Recruiting nowThis study tests a new surgical technique for people with glioblastoma, an aggressive brain cancer. Surgeons place a piece of the patient's own tissue (from the scalp or skull lining) into the area where the tumor was removed. This tissue flap may help bypass the blood-brain barr…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: NA • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New radiation combo shows promise in tough brain cancer battle
Disease control Recruiting nowThis study tests a new drug, TLX101-Tx, that delivers radiation directly to glioblastoma cells. It is combined with standard chemotherapy (lomustine) and compared to chemotherapy alone in 50 adults whose brain cancer has returned after initial treatment. The goal is to see if the…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Sound waves could boost brain cancer drug delivery
Disease control Recruiting nowThis Phase 3 trial tests whether combining the drug Avastin with a focused ultrasound system (NaviFUS) can improve outcomes for people with recurrent glioblastoma, an aggressive brain cancer. The ultrasound temporarily opens the blood-brain barrier to let more drug reach the tumo…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Precision radiation boost aims to outsmart deadly brain cancer
Disease control Recruiting nowThis study tests whether giving a higher radiation dose to the most aggressive parts of a glioblastoma tumor, as seen on a special FDOPA PET scan, can help people live longer. It includes 75 adults who are too frail for standard treatment or had only a partial surgery or biopsy. …
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a new combo therapy extend life in aggressive brain cancer?
Disease control Recruiting nowThis study tests whether adding the drug ruxolitinib to standard treatment (radiation and temozolomide) helps people with newly diagnosed glioblastoma live longer. About 190 adults will be randomly assigned to receive either the standard treatment alone or standard treatment plus…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Gene-Edited stem cells may let doctors use stronger chemo against brain cancer
Disease control Recruiting nowThis study tests a new approach for people with a recently removed glioblastoma (a fast-growing brain tumor). Doctors take some of the patient's own blood stem cells, add a protective gene (P140K MGMT) to them, and return them to the patient. This allows the use of higher doses o…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Leland Metheny • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC